ACATOTCServices-Educational ServicesFiscal year ends December 31

NP Life Sciences Health Industry Group Inc.

Financials through Q4 FY2023, quarter ended Dec 31, 2023Last filing: 10-K on Apr 16, 2024

$10.00+0.00 (0.00%)

Close on Oct 19, 2026

Market cap: $429.60M
P/E (TTM): –
Dividend yield: –

Debt

Borrowings on the balance sheet, Dec 31, 2023

NP Life Sciences Health Industry reports no long-term debt line

Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.

Bond issues

Individual notes and bonds outstanding

Bond-level data is not connected yet

Coupon, maturity and amount of each note will come from the debt footnote in NP Life Sciences Health Industry's annual report. Trading prices and yields need FINRA TRACE data.

Where these numbers come from

Parsed from the XBRL in NP Life Sciences Health Industry's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-10 reverse split on Oct 28, 2025
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is ACAT.

Revenue growth61.4% · median -30.9%

Operating margin-0.4% · median -122.4%

Net margin-1.8% · median -121.9%

Company	Revenue	Growth
AACG	CN¥268.11M	+0.0%
KPEA	$593.24K	-61.8%
ACAT	$164.62K	+61.4%
EDU	–	–
EEIQ	–	–
ZCMD	–	–

Company

Exchange: OTC
Industry: Services-Educational Services
Fiscal year ends: December 31
Auditor: WWC, P.C.
SEC CIK: 1781726

Advertisement
300 × 250